Jan Hoflack

Currently holds a position at Oncodesign SA

Position	Company	Period
Member of the Management Committee and Deputy Chief Executive Officer, Chief Scientific Officer, Head of Discovery Division	Oncodesign SA	June 2, 2010 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-12-19	2022-12-08	Oncodesign Precision Medicine Opm SA (ALOPM)	B Purchase	21,603 252.07 €4,506,772	21,603	252.07	€4,506,772
2022-10-20	2022-10-18	Oncodesign SA (ALONC)	S Sale	47,930 467.97 €3,567,316	47,930	467.97	€3,567,316